EA201190243A1 - Стабильная фармацевтическая композиция флударабина фосфата - Google Patents

Стабильная фармацевтическая композиция флударабина фосфата

Info

Publication number
EA201190243A1
EA201190243A1 EA201190243A EA201190243A EA201190243A1 EA 201190243 A1 EA201190243 A1 EA 201190243A1 EA 201190243 A EA201190243 A EA 201190243A EA 201190243 A EA201190243 A EA 201190243A EA 201190243 A1 EA201190243 A1 EA 201190243A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
stable pharmaceutical
fludarabin phosphate
phosphate
fludarabin
Prior art date
Application number
EA201190243A
Other languages
English (en)
Inventor
Ивета Дэнс
Original Assignee
Гриндекс, Э Джоинт Сток Кампани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гриндекс, Э Джоинт Сток Кампани filed Critical Гриндекс, Э Джоинт Сток Кампани
Publication of EA201190243A1 publication Critical patent/EA201190243A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Стабильная фармацевтическая композиция, содержащая флударабина фосфат в качестве активного ингредиента.
EA201190243A 2009-05-19 2010-05-19 Стабильная фармацевтическая композиция флударабина фосфата EA201190243A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09160620 2009-05-19
PCT/EP2010/056878 WO2010133629A1 (en) 2009-05-19 2010-05-19 Stable pharmaceutical composition of fludarabine phosphate

Publications (1)

Publication Number Publication Date
EA201190243A1 true EA201190243A1 (ru) 2013-01-30

Family

ID=40846159

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190243A EA201190243A1 (ru) 2009-05-19 2010-05-19 Стабильная фармацевтическая композиция флударабина фосфата

Country Status (3)

Country Link
EP (1) EP2432457A1 (ru)
EA (1) EA201190243A1 (ru)
WO (1) WO2010133629A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102525996A (zh) * 2012-03-15 2012-07-04 山东新时代药业有限公司 一种含磷酸氟达拉滨的胶囊剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
US20090306101A1 (en) * 2005-11-11 2009-12-10 Flavio Solca Combination treatment of cancer comprising egfr/her2 inhibitors

Also Published As

Publication number Publication date
WO2010133629A1 (en) 2010-11-25
EP2432457A1 (en) 2012-03-28

Similar Documents

Publication Publication Date Title
CY1121843T1 (el) Σκευασματα ετανερσεπτης σταθεροποιημενα με ιοντα μαγνησιου
EA201300146A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
EA201270216A1 (ru) Фармацевтический состав
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
MX2013001677A (es) Formulaciones estables de linaclotida.
PH12014502462A1 (en) Complement pathway modulators and uses thereof
EA201270590A1 (ru) Ингибиторы акт
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
MX350447B (es) Composicion farmaceutica de disolucion rapida.
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
MX2014001368A (es) Soluciones anti-inflamatorias estables para inyección.
MX2016001422A (es) Composicion farmaceutica de fingolimod.
EA201300857A1 (ru) Пиразолы в качестве антагонистов crth2
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
EA201400444A1 (ru) Производные 2-оксопиперидинила
EA201190243A1 (ru) Стабильная фармацевтическая композиция флударабина фосфата
TR201010859A2 (tr) Sefdinir içeren tablet formları.
TR201009166A2 (tr) Sefdinir içeren farmasötik bileşim için üretim yöntemi
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.